CORONAVIRUS NEWS

Genes associated with high risk of severe COVID-19

Scientists from PrecisionLife have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled precision medicine platform to analyse the genomes of 929 patients who had a severe response to SARS-CoV-2.

COVID-19: impact on the NTM patient

A free webinar on COVID-19 and the impact on the non-tuberculous mycobacteria (NTM) patient will be held on Wednesday, 8 July at 5.00 pm. Click on this news item for registration details.

Una Health and Fortress Diagnostics partner with the DHSC

Una Health, a distributor of in vitro diagnostics (IVDs), and Fortress Diagnostics, a provider of IVDs, are partnering with the Department of Health & Social Care in the Real Time Assessment of Community Transmission (REACT) study into COVID-19.

Use of digital pathology for remote diagnosis

Hamamatsu Photonics invites you to join a panel discussion with pathologist Dr Matthew Hanna and IT Manager Nikolas Stathonikos on Thursday 9 July 2020 (4.00 pm BST, 11.00 am EDT, 5.00 pm CET). Click on this item for the link to register.

Haematology biomarkers for COVID-19 assessment: an HORIBA white paper

HORIBA UK, Medical has published a white paper entitled ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients’. The paper provides a review of biomarkers that help in the assessment of COVID-19 severity.

Update on SARS-CoV-2 rapid antigen test development

Avacta Group has announced that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data.

Pipetting solutions to make SARS-CoV-2 extraction faster and easier

The SARS-CoV-2 pandemic has placed unprecedented pressure on research and diagnostic laboratories to process more samples more quickly. INTEGRA Biosciences offers a range of pipetting systems designed to speed up PCR-based screening workflows.

Predictive sepsis test for coronavirus patients funded by MOD

Ploughshare Innovations, a Defence Science and Technology Laboratory (Dstl) spin-out firm, has funded the development of a revolutionary test that has the potential to predict whether coronavirus patients will develop sepsis before symptoms appear.

SARS-CoV-2 droplet digital polymerase chain reaction test

Bio-Rad provides a wide range of products for use in the support of COVID-19 diagnosis and confirmation, and offers a suite of molecular testing tools including Droplet Digital PCR (ddPCR) systems and the SARS-CoV-2 ddPCR test kit.

Update on Affimer reagent therapy for SARS-CoV-2 infection

Infectivity assays carried out by the Avacta Group in collaboration with the Centre for Virus Research at the University of Glasgow show that the company’s Affimer reagents prevent infection of human cells by a SARS-CoV-2 model virus.

Adapt and succeed in challenging laboratory times

The Royal Society reports that every £1 invested in medical research delivers a return equivalent of around 25 pence every year, forever. Here, Katie Gray explains how UK laboratories are remaining productive during the lockdown.

Danish robots assist in European testing for SARS-CoV-2 coronavirus

A Danish pipetting robot is automating coronavirus testing processes in European hospitals. The robot, called flowbot ONE, significantly reduces the time it takes for laboratories to produce results for patients potentially infected with SARS-CoV-2.

Safer ELISA antibody testing with convenient buffer removal

The SARS-CoV-2 pandemic has led to the development of novel RT-PCR-based tests to detect the virus. As the situation has progressed, serology tests are now needed to evaluate the immune response of patients, and assess immunity in the general public.

SARS-CoV-2 IgM and IgG detection from whole blood, serum and plasma

The ScheBo SARS-CoV-2 Quick is a combined immunochromatographic lateral-flow test for the simultaneous qualitative detection of SARS-CoV-2 IgM and IgG antibodies in whole blood, serum or plasma, with test results after 15 minutes.

SARS-CoV-2 kit for research into measuring the T-cell immune response

Oxford Immunotec has released the T-SPOT Discovery SARS-CoV-2 test kit. This could make a significant contribution to development of a tool to manage the current pandemic, and help nations come out of lockdown faster, safer and in a controlled manner

SARS-CoV-2 IgG antibody test now available in the UK and Europe

Beckman Coulter’s Access SARS-CoV-2 IgG assay is now available in markets accepting the CE mark. The company has shipped tests to more than 400 hospitals, clinics and laboratories in the USA, and has begun shipping to customers globally.

Cytokine testing for COVID-19 risk and treatment monitoring

An innovative method of monitoring treatment efficacy and recovery from COVID-19 has been unveiled by global diagnostics company Randox Laboratories. The test detects the presence of cytokines, and is performed on the company’s Biochip Technology.

Significant leap forward for SARS-CoV-2 detection

PCR Biosystems has launched qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultrasensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.

Hand sanitisers: do they work against SARS-CoV-2 coronavirus?

It seems bizarre that at the time of writing, we are into the fourth month of a viral pandemic, and yet only one of many available disinfectant and hand sanitiser chemistries had been tested against SARS-CoV-2 coronavirus. Andrew Kemp explains.

Set up heparin assay protocols quickly and remotely

The NHS has announced that heparin is to be trialled on critically-ill COVID-19 patients, putting more pressure on laboratories to set up new anti-Xa assay protocols. Stago UK is able to help remotely using its Connect.One data sharing middleware.